Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

Skin
29:16

Insights from 2023 IGCS Annual Meeting

IGCS 2023 Insights: "Vulvovaginal Melanoma - Current Approaches & Emerging Therapeutic Options"

FEATURING Mario Leitao
  • 49 views
  • December 19, 2023
24:53

OncoAlert

Recent Melanoma Updates

FEATURING Allison Betof Warner
  • 395 views
  • March 1, 2023
04:04

GRACE

Clinical Trials in Melanoma

FEATURING Michael Postow
  • 56 views
  • January 19, 2023
  • 1
02:49

GRACE

Major Advances in Uveal Melanoma

FEATURING Michael Postow
  • 514 views
  • January 19, 2023
  • 2
04:28

GRACE

BRAF Mutated Melanoma

FEATURING Michael Postow
  • 302 views
  • January 19, 2023
03:10

GRACE

Side Effects of Immunotherapy in Melanoma

FEATURING Michael Postow
  • 27 views
  • January 19, 2023
08:00

GRACE

Immunotherapy in Treatment of Melanoma

FEATURING Michael Postow
  • 148 views
  • January 19, 2023
05:50

GRACE

Melanoma and Current Treatment Options

FEATURING Michael Postow
  • 233 views
  • January 19, 2023
11:42

Memorial Sloan Kettering Cancer Center

Who Should Be Getting Adjuvant Therapy in Melanoma?

FEATURING Allison Betof Warner
  • 422 views
  • November 30, 2022
47:34

Massachusetts General Hospital Cancer Center

Confronting Inequity in Modern Therapy for Rare Melanomas

FEATURING Alexander Shoushtari
  • 75 views
  • June 25, 2022
10:11

Memorial Sloan Kettering Cancer Center

2022 Updates in the Treatment of Melanoma

FEATURING Michael Postow
  • 930 views
  • March 29, 2022
  • 7
06:32

Memorial Sloan Kettering Cancer Center

2021 ASCO Highlights on 1L Treatment for Advanced Melanoma: RELATIVITY-047 Phase III Study of Relatlimab + Nivolumab vs. Nivolumab Alone

FEATURING Allison Betof Warner
  • 50 views
  • July 12, 2021
15:05

Memorial Sloan Kettering Cancer Center

2020 Updates on Stage 4 Melanoma: Do BRAF+ MEK Combos Improve PFS? Is Nivo+Ipi More Beneficial for PFS/OS vs. Nivo/Ipi Mono? What About Cobimetinib+Vemurafenib+Atezo Triplet Therapy?

FEATURING Allison Betof Warner
  • 301 views
  • November 27, 2020
  • 1
13:02

2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Skin Toxicities are First and Frequent in Immunotherapy

FEATURING Mario Lacouture
  • 128 views
  • September 10, 2019
14:10

Weill Cornell Medicine Courses and Meetings

Systemic Therapy for Melanoma Brain Metastases: RAF/MEK Inhibitors and PD-1 and CTLA-4 Combination Immunotherapy

FEATURING Paul Chapman
  • 89 views
  • June 10, 2019